Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10594066 | Bioorganic & Medicinal Chemistry Letters | 2011 | 4 Pages |
Abstract
Compound 11 displayed the most potent EGFR TK inhibitory activity with IC50 of 0.06 μM, which was comparable to the positive control. Molecular docking results indicated that compound 11 was nicely bound to the EGFR kinase with three hydrogen bonds. Compound 11 also showed significant antiproliferative activity against MCF-7 with IC50 of 0.07 μM, which would be a potential anticancer agent.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Peng-Cheng Lv, Dong-Dong Li, Qing-Shan Li, Xiang Lu, Zhu-Ping Xiao, Hai-Liang Zhu,